Carolina Cancer Screening Initiative
Cancer Prevention and Control
Daniel Reuland, MD, MPH, is a professor of medicine at the University of North Carolina School of Medicine in the Division of General Internal Medicine and Clinical Epidemiology. He attended medical school at Johns Hopkins University and did his internal medicine residency at Yale – New Haven Hospital. He practiced and taught internal medicine for 11 years (including 4 years with the U.S. Indian Health Service) before deciding to focus on research and enter a post-doctoral fellowship at the UNC Cecil G. Sheps Center for Health Services Research. He completed the fellowship and MPH degree at the UNC Gillings School of Global Public Health in 2008, after which he rejoined the UNC faculty as a health services researcher. His research interests include developing, testing, and implementing interventions aimed at improving clinical communication, decision making, and health behaviors within primary care practice and health systems. Much of his work aims to enhance our understanding of how to make cancer screening more appropriate, patient-centered, and effective.
Area of Interest
Reuland’s primary areas of inquiry are in cancer prevention and control, though he collaborates on studies in other disease areas. He is currently principal investigator of a multi-site, clinical trial funded by the National Cancer Institute’s Accelerating Cancer Screening and Follow Up through Implementation Science (ACCSIS) Program testing a colorectal cancer screening intervention in North Carolina Federally Qualified Health Centers. He recently led a multi-disciplinary effort to develop policies, processes, and tools needed for appropriate implementation of lung cancer screening within the UNC Health Care System, and he is the PI on a National Cancer Institute research grant to develop and test lung cancer screening decision support tools. Reuland is the Director of the Carolina Cancer Screening Initiative, supported by the UNC Lineberger Comprehensive Cancer Center and University Cancer Research Fund, which focuses on improving the delivery of evidence-based cancer screening in North Carolina. He also serves as Associate Director of the Inclusive Science Program within the North Carolina Translational and Clinical Sciences Institute.
Reuland holds appointments in the UNC Lineberger Comprehensive Cancer Care Center – Cancer Prevention and Control Program, Cecil G. Sheps Center for Health Services Research, and the North Carolina Translational and Clinical Sciences Institute.
Awards and Honors
- Member, North Carolina Advisory Committee on Cancer Coordinator and Control, 2021
- Associate Director, Inclusive Science Program (ISP), Community Engagement Core, NC Translational & Clinical Sciences Institute, 2020
- Member, National Lung Cancer Roundtable; Shared Decision-Making Task Group, 2017
- Director, Carolina Cancer Screening Initiative, UNC Lineberger Comprehensive Cancer Center, 2016
- Member, North Carolina Colorectal Cancer Roundtable (Quarterly), 2015
- Associate member, UNC Lineberger Comprehensive Cancer Center, 2010
- Co-chair, Health Disparities Scientific Abstract Review Committee; Society of General Internal Medicine (SGIM) 2011 Annual National Meeting, 2010-2011
- Appointed Research Fellow, Cecil G. Sheps Center for Health Services Research, UNC-Chapel Hill, 2010
- Recipient of American Cancer Society’s Cancer Control Career Development Award (CCCDA) for Primary Care Physicians, 2009-2012
- Nominee, Graduate School Impact Award, UNC-Chapel Hill, 2009
- Member, UNC Program on Health Literacy (Darren DeWalt, MD, MPH, Director), 2008
- Co-director, UNC Center for Latino Health, 2007
- University of North Carolina, K30 Scholar, 2006-2008
- Co-director, Comprehensive Advanced Medical Program of Spanish (CAMPOS), School of Medicine, UNC-Chapel Hill, 2004
News and Stories
Experts recommend shared decision-making between a patient and doctor prior to lung cancer screening
Daniel Reuland, MD, MPH, believes that a physician should ask about a patient’s informed values and preferences regarding key tradeoffs of lung cancer screening and use that information to reach a decision that makes sense for the patient.
Evidence review examines both benefits and harms for lung cancer screening
A comprehensive review of articles on lung cancer prevention screening with low-dose spiral computed tomography shows there are both benefits and harms from screening.
UNC Lineberger partners with NC Health and Human Services and American Cancer Society to increase colorectal cancer screening in vulnerable populations
The North Carolina Partnerships to Increase Colorectal Cancer Screening (NC PICCS) will use the five-year grant to increase colorectal cancer screening and provide follow-up services for program-eligible people.
Henderson, Rivera awarded $1.5 million lung cancer screening study grant
Louise Henderson, PhD, M. Patricia Rivera, MD, ATSF, and a multi-disciplinary team will study comorbidity and functional status in a population undergoing lung cancer screening.